Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo, and seen here in New York 2024 Ian Haddock participated in a trial of lenacapavir.
Mandatory Credit: Bryan Bedder/Getty Images via CNN Newsource
Stories this photo appears in:
FDA approves twice-a-year injection for HIV prevention
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.
